A study to investigate the safety, tolerability, and pharmacokinetics (PK) of oral AZD6793 in healthy subjects

Trial Identifier:	D7860C00001
Sponsor:	AstraZeneca
NCTID::	NCT05662033
Start Date:	December 2022
Primary Completion Date:	August 2023
Study Completion Date:	August 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Harrow, GB, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.